(MRX) Mister Spex SE - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A3CSAE2

MRX: Prescription Glasses, Sunglasses, Contact Lenses

Mister Spex SE is a leading European omnichannel retailer specializing in eyewear, operating primarily in Germany and internationally. The company offers a wide range of prescription glasses, sunglasses, and contact lenses, catering to diverse consumer preferences. Its product portfolio includes independent labels, proprietary brands, and a selection of premium and luxury brands. Mister Spex SE distributes its products through multiple channels, including its own online shops, retail stores, and a network of partner opticians. This omnichannel approach allows the company to reach a broad customer base while maintaining a strong brand presence. Established in 2007 and headquartered in Berlin, Germany, Mister Spex SE has grown to become a significant player in the European eyewear market, leveraging its e-commerce expertise and physical retail network to drive growth.

From a technical perspective, MRX shares have shown bearish momentum, trading below their SMA 20 and SMA 50 levels of 1.63 and 1.62, respectively. The stock is currently priced at 1.58, reflecting a decline from its SMA 200 level of 2.25. The Average True Range (ATR) of 0.06 indicates low volatility, suggesting limited price fluctuations in the near term. The stocks average 20-day volume of 22,034 shares highlights moderate trading activity.

Fundamentally, Mister Spex SE has a market capitalization of 75.31 million EUR, with a price-to-book (P/B) ratio of 0.54, indicating that the stock is trading below its book value. The price-to-sales (P/S) ratio of 0.31 suggests undervaluation relative to its revenue. However, the return on equity (RoE) of -34.78% reflects significant profitability challenges, which may impact investor sentiment. The lack of positive P/E and forward P/E ratios further underscores the companys current financial struggles.

Over the next three months, MRX shares are expected to remain under pressure due to the stocks bearish technical setup and weak fundamental metrics. The decline below the SMA 20 and SMA 50 suggests limited upside potential, with resistance likely at 1.63. Support levels may be tested near the recent lows, given the lack of positive momentum indicators. The low ATR of 0.06 suggests that price movements will remain subdued, with minimal volatility expected. Fundamentally, the companys negative RoE and lack of profitability could continue to weigh on investor sentiment, potentially limiting any near-term recovery. However, the low P/S ratio of 0.31 may attract value investors if the company demonstrates progress in addressing its profitability challenges.

Additional Sources for MRX Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MRX Stock Overview

Market Cap in USD 51m
Sector Consumer Cyclical
Industry Specialty Retail
GiC Sub-Industry Other Specialty Retail
IPO / Inception

MRX Stock Ratings

Growth Rating -82.3
Fundamental -15.8
Dividend Rating 0.0
Rel. Strength -59.7
Analysts -
Fair Price Momentum 0.68 EUR
Fair Price DCF -

MRX Dividends

No Dividends Paid

MRX Growth Ratios

Growth Correlation 3m -69.3%
Growth Correlation 12m -93.4%
Growth Correlation 5y -94.1%
CAGR 5y -53.55%
CAGR/Max DD 5y -0.56
Sharpe Ratio 12m -0.07
Alpha -62.82
Beta 0.213
Volatility 62.88%
Current Volume 9.7k
Average Volume 20d 12.1k
What is the price of MRX stocks?
As of April 25, 2025, the stock is trading at EUR 1.25 with a total of 9,675 shares traded.
Over the past week, the price has changed by -5.66%, over one month by -25.15%, over three months by -24.24% and over the past year by -54.71%.
Is Mister Spex SE a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Mister Spex SE is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRX as of April 2025 is 0.68. This means that MRX is currently overvalued and has a potential downside of -45.6%.
Is MRX a buy, sell or hold?
Mister Spex SE has no consensus analysts rating.
What are the forecast for MRX stock price target?
According to ValueRays Forecast Model, MRX Mister Spex SE will be worth about 0.7 in April 2026. The stock is currently trading at 1.25. This means that the stock has a potential downside of -41.6%.
Issuer Forecast Upside
Wallstreet Target Price 4.2 232%
Analysts Target Price - -
ValueRay Target Price 0.7 -41.6%